Risks and Benefits of SGLT-2 Inhibitor Agents

Volume 2, Issue 11.

Anne Peters, MD covers the important topic of Risks and Benefits of SGLT-2 Inhibitor Agents in the format of case-study scenarios for the clinical practice.

Leave a Reply

Your email address will not be published. Required fields are marked *